Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioavailability of Ambroxol Soft Pastilles vs Syrup
NCT02194270Phase 1Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Sep 2004
- Primary completion
- Feb 2005
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, open-label trial of ambroxol in bronchopulmonary diseases (3 arms), sponsored by Boehringer Ingelheim. Primary endpoints: Area under the concentration-time curve from 0 to infinity up to 30 hours and Maximum plasma concentration up to 30 hours. Started Sep 2004; status: completed.
02
Drugs
ambroxol
03
Conditions
bronchopulmonary diseases
Beyond the preview
Go deeper on NCT02194270.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02194270.